Louis Villalba

Louis Villalba

Chief Executive Officer at TMRW Life Sciences, Inc.

55 year
Health Technology
Commercial Services
Consumer Services

Profile

Louis S.
Villalba
is currently the Chief Executive Officer at TMRW Life Sciences, Inc. He is also a Director at 2591046 Ontario Corp., Bombax Healthcare Acquisition Corp., and Myocea.
Previously, he served as the Chief Executive Officer at Genea Biomedx UK Ltd.
and as the Vice President & Managing Director-Europe at Conceptus, Inc. He was also a Product Manager at Collagen Corp.
and the Chief Business Officer at Evofem, Inc. Additionally, he held the position of General Manager-Europe at Conceptus SAS and Vice President-Sales at Auxogyn, Inc. He served as the Senior Vice President-Corporate Development at OvaScience, Inc. Mr. Villalba completed his undergraduate degree at Menlo College.

Louis Villalba active positions

CompaniesPositionStart
Director/Board Member -
Director/Board Member -
Myocea Director/Board Member -
Chief Executive Officer 2023-06-26
All active positions of Louis Villalba

Former positions of Louis Villalba

CompaniesPositionEnd
Corporate Officer/Principal 2017-12-31
Corporate Officer/Principal 2014-12-31
Sales & Marketing 2013-12-31
Corporate Officer/Principal 2012-12-31
Collagen Corp. Corporate Officer/Principal 2000-12-31
See the detail of Louis Villalba's experience

Training of Louis Villalba

Menlo College Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Louis Villalba's experience

Connections

42

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies11

Health Technology

Collagen Corp.

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Technology Services

Finance

Myocea

See company connections
  1. Stock Market
  2. Insiders
  3. Louis Villalba
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW